Related Experiment Video

Updated: Jan 4, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.6K

Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia

Victor E F da Costa1, Rafael D de Oliveira1, Fabíola Traina1

  • 1Hematology Division, Department of Medical Images, Hematology and Clinical Oncology at Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.

British Journal of Haematology
|November 5, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BCR-ABL1BCR-ABL1-negative myeloproliferative neoplasmCALR gene mutationchronic myeloid leukaemiaessential thrombocythaemia

More Related Videos

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.4K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.2K

Related Experiment Videos

Last Updated: Jan 4, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.6K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.4K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.2K

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

1.7K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.8K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K

Articles linked to this work by shared authors, journal, and citation graph.

Prospective Longitudinal Salivary and Plasma Cytokine Profiling in Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026

Chlorhexidine antiseptic is a harmful protection due to keratitis and blindness potential.

The ocular surface·2026

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Haematologica·2026

The murine Irs1 knockout model, generated by the spontaneous Irs1S57X mutation in homozygosity, exhibits high embryonic lethality, limiting studies of adult hematopoiesis.

Hematology, transfusion and cell therapy·2026

SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL).

Clinical lymphoma, myeloma & leukemia·2026

Intravitreal Bevacizumab plus Methotrexate for iris and ciliary body metastasis from lung cancer.

American journal of ophthalmology case reports·2026

Association of enlarged perivascular space burden with silent cerebral infarcts in children with sickle cell disease.

British journal of haematology·2026

Identification of rare blood group donors from biobank data.

British journal of haematology·2026

Subtype- and functional class-dependent prognostic impact of CSF3R mutations in acute myeloid leukaemia: A cohort study of 2500 patients.

British journal of haematology·2026

Sustained improvement in sickle cell cardiomyopathy after haematopoietic stem cell transplantation is superior to that with disease-modifying therapy.

British journal of haematology·2026

CD19+ CD 38+ regulatory B lymphocytes as exploratory prognostic markers of steroid-induced remission in treatment-naïve adult immune thrombocytopenia.

British journal of haematology·2026

Paediatric haematopoietic stem cell transplantation research priorities: Results from an international multi-stakeholder priority setting partnership.

British journal of haematology·2026

Catching Two Birds with One Stone: A Primary Open Revascularisation First Approach in a Case Report of Chronic Mesenteric Ischaemia.

EJVES vascular forum·2026

Bilateral Versus Unilateral Middle Meningeal Artery Embolization for Standalone Treatment of Unilateral Chronic Subdural Hematoma.

AJNR. American journal of neuroradiology·2026

Plasma protein profiles in Bleeding Disorder of Unknown Cause.

Journal of thrombosis and haemostasis : JTH·2026

Hemophagocytic Lymphohistiocytosis Thought to Be due to Undifferentiated Connective Tissue Disease Treated With Ruxolitinib: A Case Report.

Case reports in rheumatology·2026

Tirofiban vs standard antiplatelet therapy in acute branch atheromatous disease-related stroke: a multicenter, randomized, open-label, blinded-endpoint, parallel-group, phase III clinical trial.

The Lancet regional health. Western Pacific·2026

Heavy menstrual bleeding in women with a bleeding disorder of unknown cause: a common symptom impacting daily life functioning.

Research and practice in thrombosis and haemostasis·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us